# Mitek Systems Inc: Form 10-Q for the period ended Mar 31, 2021

- Company: [Mitek Systems Inc](/companies/mitk.md) (CIK 807863)
- Form: 10-Q
- Filed: 2021-05-06
- Accepted by EDGAR: May 6, 2021, 16:51 ET
- Period: 2021-03-31
- Accession: 0000807863-21-000063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/807863/000080786321000063/mitk-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/807863/000080786321000063/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $28.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2020-10-01 to 2021-03-31 | $54.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months, 2021-01-01 to 2021-03-31 | $6.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2020-10-01 to 2021-03-31 | $12.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | $2.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2020-10-01 to 2021-03-31 | $3.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $1.3m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2020-10-01 to 2021-03-31 | $1.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $417.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2020-10-01 to 2021-03-31 | −$117.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | $1.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2020-10-01 to 2021-03-31 | $3.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2020-10-01 to 2021-03-31 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2020-10-01 to 2021-03-31 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 44,554,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2020-10-01 to 2021-03-31 | 44,367,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2020-10-01 to 2021-03-31 | $16.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2020-10-01 to 2021-03-31 | $660.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2020-10-01 to 2021-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-03-31 | $53.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $207.2m | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $355.8m | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $24.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-03-31 | $188.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-03-31 | $167.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 48,690 characters.

*This Quarterly Report on Form 10-Q (this “Form 10-Q”), contains “forward-looking statements” that involve risks and uncertainties, as well as assumptions that, if they never materialize or they prove incorrect, could cause our results to differ materially and adversely from those expressed or implied by such forward-looking statements. The forward-looking statements are contained principally in Part I, Item 2—“Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 1A—“Risk Factors,” but appear throughout this Form 10-Q. Forward-looking statements may include, but are not limited to, statements relating to our outlook or expectations for earnings, revenues, expenses, asset quality, volatility of our common stock, financial condition or other future financial or business performance, strategies, expectations, or business prospects, the duration and impact of the novel COVID-19 pandemic on our business, our customers, and markets generally, or the impact of legal, regulatory, or supervisory matters on our business, results of operations, or financial condition.*

*Forward-looking statements can be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “target”, “will,” “would,” “could,” “can,” “may”, or similar expressions. Forward-looking statements reflect our judgment based on currently available information and involve a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in Part II, Item 1A—“Risk Factors” in this Form 10-Q and in our other filings with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, filed with the U.S. Securities and Exchange Commission on December 7, 2020, as amended by Amendment No. 1 to the Annual Report on Form 10-K/A (the “Form 10-K”), filed with the SEC on December 11, 2020. Additionally, there may be other factors that could preclude us from realizing the predictions made in the forward-looking statements. We operate in a continually changing business environment and new factors emerge from time to time. We cannot predict such factors or assess the impact, if any, of such factors on our financial position or results of operations. All forward-looking statements included in this Form 10-Q speak only as of the date of this Form 10-Q and you are cautioned not to place undue reliance on any such forward-looking statements. Except as required by law, we undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect any events or circumstances after the date of this Form 10-Q or to reflect the occurrence of unanticipated events.*

*In this Form 10-Q, unless the context indicates otherwise, the terms “Mitek,” “the Company,” “we,” “us,” and “our” refer to Mitek Systems, Inc., a Delaware corporation and its subsidiaries.*

### Overview

Mitek is a leading innovator of mobile image capture and digital identity verification solutions. We are a software development company with expertise in computer vision, artificial intelligence, and machine learning. We are currently serving more than 7,500 financial services organizations and leading marketplace and financial technology (“fintech”) brands across the globe. Our solutions are embedded in native mobile apps and browsers to facilitate better online user experiences, fraud detection and reduction, and compliant transactions.

Mitek’s Mobile Deposit® solution is used today by millions of consumers in the United States (“U.S.”) and Canada for mobile check deposit. Mobile Deposit® enables individuals and businesses to remotely deposit checks using their camera-equipped smartphone or tablet. Our Mobile Deposit® solution is embedded within the financial institutions’ digital banking apps used by consumers and has now processed approximately five billion check deposits. Mitek began selling Mobile Deposit® in early 2008 and received its first patent for this product in August 2010.

Mitek’s Mobile Verify® verifies a user’s identity online enabling organizations to build safer digital communities. Scanning an identity document helps enable an enterprise to verify the identity of the person with whom they are conducting business, to comply with growing governmental Anti-Money Laundering and Know Your Customer regulatory requirements, and to improve the overall customer experience for digital onboarding. To be sure the person submitting the identity document is who they say they are, Mitek’s Mobile Verify Face Comparison provides an additional layer of online verification and compares the face on the submitted identity document with the live selfie photo of the user.

The combination of identity document capture and data extraction process enables the organization to prefill the end user’s application, with far fewer key strokes, thus reducing keying errors, and improving both operational efficiency and the customer experience. Today, the financial services verticals (banks, credit unions, lenders, payments processors, card issuers, fintech companies, etc.) represent the greatest percentage of use of our solutions, but there is accelerated adoption by marketplaces, sharing economy, and hospitality sectors. Mitek uses artificial intelligence and machine learning to constantly improve the product performance of Mobile Verify® such as speed and accuracy of approvals of identification documents. The core of our user experience is driven by Mitek MiSnap™, the leading image capture technology, which is incorporated across our product lines. It provides a simple, intuitive, and superior user-experience, making digital transactions faster, more accurate, and easier for the consumer. Mobile Fill® automates application prefill of any form with user data by simply snapping a picture of the driver’s license or other similar user identity document.

CheckReader™ enables financial institutions to automatically extract data from a check image received across any deposit channel—branch, ATM, remote deposit capture, and mobile. Through the automatic recognition of all fields on checks, whether handwritten or machine print, CheckReader™ speeds the time to deposit for financial institutions and enables them to comply with check clearing regulations.

We market and sell our products and services worldwide through internal, direct sales teams located in the U.S., Europe, and Latin America as well as through channel partners. Our partner sales strategy includes channel partners who are financial services technology providers and identity verification providers. These partners integrate our products into their solutions to meet the needs of their customers.

### Second Quarter Fiscal 2021 Highlights

- Revenue for the three months ended March 31, 2021 was $28.8 million, an increase of 24% compared to revenue of $23.2 million in the three months ended March 31, 2020.
- Net income was $1.0 million, or $0.02 per diluted share, during the three months ended March 31, 2021, compared to net income of $0.9 million, or $0.02 per share, during the three months ended March 31, 2020.
- Cash provided by operating activities was $16.1 million for the six months ended March 31, 2021, compared to $8.4 million for the six months ended March 31, 2020.
- We added new patents to our portfolio during the second quarter of fiscal 2021 bringing our total number of issued patents to 71 as of March 31, 2021. In addition, we have 17 domestic and international patent applications pending as of March 31, 2021.

### Market Opportunities, Challenges & Risks

We believe that financial institutions, fintechs, and other companies see our patented solutions as a way to provide a superior digital customer experience to meet growing consumer demand for trust and convenience online and, at the same time, assist them in meeting regulatory requirements. The value of digital transformation to our customers is a possible increase in top line revenue and a reduction in the cost of sales and services. As the use of new technology increases, so does associated fraud and cyber-attacks. The negative outcomes of fraud encompass financial losses, brand damage, and loss of loyal customers. We predict growth in both our deposits and identity verification products based on current trends in payments, online lending, more stringent regulations, growing usage of sharing apps and online marketplaces, and the ever-increasing demand for digital services.

Factors adversely affecting the pricing of, or demand for, our digital solutions, such as competition from other products or technologies, any decline in the demand for digital transactions, or negative publicity or obsolescence of the software environments in which our products operate, could result in lower revenues or gross margins. Further, because substantially all of our revenues are from a few types of technology, our product concentration may make us especially vulnerable to market demand and competition from other technologies, which could reduce our revenues.

The sales cycle for our software and services can be lengthy and the implementation cycles for our software and services by our channel partners and customers can also be lengthy, often as long as six months and sometimes longer for larger customers. If implementation of our products by our channel partners and customers is delayed or otherwise not completed, our business, financial condition, and results of operations may be adversely affected.

Revenues related to most of our on-premise licenses for mobile products are required to be recognized up front upon satisfaction of all applicable revenue recognition criteria. Revenue related to our software as a service (“SaaS”) products is recognized ratably over the life of the contract or as transactions are used depending on the contract criteria. The recognition of future revenues from these licenses is dependent upon a number of factors, including, but not limited to, the term of our license agreements, the timing of implementation of our products by our channel partners and customers, and the timing of any re-orders of additional licenses and/or license renewals by our channel partners and customers.

During each of the last few years, sales of licenses to one or more channel partners have comprised a significant part of our revenue each year. This is attributable to the timing of renewals or purchases of licenses and does not represent a dependence on any single channel partner. If we were to lose a channel partner relationship, we do not believe such a loss would adversely affect our operations because either we or another channel partner could sell our products to the end-users that had purchased products from the channel partner we lost. However, in that case, we or another channel partner must establish a relationship with the end-users, which could take time to develop, if it develops at all.

We have a growing number of competitors in the mobile image capture and identity verification industry, many of which have greater financial, technical, marketing, and other resources. However, we believe our patented mobile image capture and identity verification technology, our growing portfolio of products and geographic coverage for the financial services industry, and our market expertise gives us a distinct competitive advantage. To remain competitive, we must continue to offer products that are attractive to the consumer as well as being secure, accurate, and convenient. To help us remain competitive, we intend to further strengthen performance of our portfolio of products through research and development as well as partnering with other technology providers.

In the second quarter of fiscal 2020, concerns related to the spread of COVID-19 began to create global business disruptions as well as disruptions in our operations and to create potential negative impacts on our revenues and other financial results. COVID-19 was declared a pandemic by the World Health Organization on March 11, 2020. In an effort to contain COVID-19 or slow its spread, governments around the world have enacted various measures, including orders to close all businesses not deemed “essential,” isolate residents to their homes or places of residence, and practice social distancing when engaging in essential activities. We anticipate that these actions and the global health crisis caused by COVID-19 will negatively impact business activity across the globe. The extent to which COVID-19 will impact our business, operations, and financial results is uncertain and difficult to predict and depends on numerous evolving factors including the duration and severity of the outbreak. See Item 1A: “Risk Factors” for additional details.

In an effort to protect the health and safety of our employees, our workforce has transitioned to working remotely and employee travel, including to our international subsidiaries, has been severely curtailed. It is not clear what the potential effects of any such alterations or modifications may have on our business, including the effects on our customers or vendors, or on our financial results. We will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by federal, state, local, or foreign authorities, or that we determine are in the best interests of our employees, customers, partners, and stockholders.

We anticipate in certain circumstances that the current stay-at-home orders and impact of the COVID-19 pandemic may accelerate the adoption of digital technologies and create future opportunities and uses for our products. However, we cannot predict what the overall impact of the COVID-19 pandemic will be on our business or financial condition as business and consumer activity decelerates across the globe. Because of our IT infrastructure and the nature of our business, our employees have generally been able to work remotely and productively despite the stay-at-home orders, but future productivity and the effects of COVID-19 on our operations is unknown at this time. We continue to seek new and innovative opportunities to serve our customers’ needs.

### Results of Operations

### Comparison of the Three Months Ended March 31, 2021 and 2020

The following table summarizes certain aspects of our results of operations for the three months ended March 31, 2021 and 2020 (*amounts in thousands, except percentages):*

| Revenue | Three Months Ended March 31, 2021 | 2020 | Percentage of Total Revenue 2021 | 2020 | Increase (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Software and hardware | $13,013 | $11,453 | 45% | 49% | $1,560 | 14% |
| Services and other | 15,760 | 11,739 | 55% | 51% | 4,021 | 34% |
| Total revenue | $28,773 | $23,192 | 100% | 100% | $5,581 | 24% |
| Cost of revenue | 3,792 | 3,186 | 13% | 14% | 606 | 19% |
| Selling and marketing | 8,530 | 6,686 | 30% | 29% | 1,844 | 28% |
| Research and development | 6,691 | 5,581 | 23% | 24% | 1,110 | 20% |
| General and administrative | 5,718 | 5,210 | 20% | 22% | 508 | 10% |
| Acquisition-related costs and expenses | 1,659 | 1,579 | 6% | 7% | 80 | 5% |
| Restructuring costs | — | (114) | —% | —% | 114 | (100)% |
| Interest expense | 1,319 | — | 5% | —% | 1,319 | 100% |
| Other income, net | 372 | 32 | 1% | —% | 340 | 1063% |
| Income tax provision | (417) | (188) | (1)% | (1)% | (229) | (122)% |
| Net income | $1,019 | $908 | 4% | 4% | $111 | 12% |

#### Revenue

Total revenue increased $5.6 million, or 24%, to $28.8 million in the three months ended March 31, 2021 compared to $23.2 million in the three months ended March 31, 2020. Software and hardware revenue increased $1.6 million, or 14%, to $13.0 million in the three months ended March 31, 2021 compared to $11.5 million in the three months ended March 31, 2020. This increase is primarily due to an increase in sales of our Mobile Deposit® and CheckReader™ software products. This increase was partially offset by a decline in revenue from our identity verification hardware products. Services and other revenue increased $4.0 million, or 34%, to $15.8 million in the three months ended March 31, 2021 compared to $11.7 million in the three months ended March 31, 2020. This increase is primarily due to continued growth in Mobile Verify® transactional SaaS revenue of $3.1 million, or 50%, in the three months ended March 31, 2021 compared to the same period in 2020, as well as an increase in maintenance revenue associated with CheckReader™ and Mobile Deposit® software sales.

#### Cost of Revenue

Cost of revenue includes personnel costs related to billable services and software support, direct costs associated with our hardware products, hosting costs, and the costs of royalties for third party products embedded in our products. Cost of revenue increased $0.6 million, or 19%, to $3.8 million in the three months ended March 31, 2021 compared to $3.2 million in the three months ended March 31, 2020. As a percentage of revenue, cost of revenue decreased to 13% in the three months ended March 31, 2021 from 14% in the three months ended March 31, 2020. The increase in cost of revenue is primarily due to an increase in cost of revenues associated with higher variable personnel, hosting and royalty costs associated with a higher volume of Mobile Verify® transactions processed during the three months ended March 31, 2021 compared to the same period in 2020.

#### Selling and Marketing Expenses

Selling and marketing expenses include payroll, employee benefits, stock-based compensation, and other headcount-related costs associated with sales and marketing personnel. Selling and marketing expenses also include non-billable costs of professional services personnel, advertising expenses, product promotion costs, trade shows, and other brand awareness programs. Selling and marketing expenses increased $1.8 million, or 28%, to $8.5 million in the three months ended March 31, 2021 compared to $6.7 million in the three months ended March 31, 2020. As a percentage of revenue, selling and marketing expenses increased to 30% in the three months ended March 31, 2021 from 29% in the three months ended March 31, 2020. The increase in selling and marketing expense is due to higher personnel-related costs resulting from our increased headcount and higher product promotion costs of $1.8 million in the three months ended March 31, 2021 compared to the same period in 2020. The overall increase in selling and marketing expense was partially offset by a decrease in travel and related expenses as a result of the COVID-19 pandemic during the three months ended March 31, 2021 as compared to the same period in 2020.

#### Research and Development Expenses

Research and development expenses include payroll, employee benefits, stock-based compensation, third party contractor expenses, and other headcount-related costs associated with software engineering and mobile capture science. Research and development expenses increased $1.1 million, or 20%, to $6.7 million in the three months ended March 31, 2021 compared to $5.6 million in the three months ended March 31, 2020. As a percentage of revenue, research and development expenses decreased to 23% in the three months ended March 31, 2021 from 24% in the three months ended March 31, 2020. The increase in research and development expenses is primarily due to higher personnel-related costs resulting from our increased headcount in the three months ended March 31, 2021 compared to the same period in 2020.

#### General and Administrative Expenses

General and administrative expenses include payroll, employee benefits, stock-based compensation, and other headcount-related costs associated with finance, legal, administration, and information technology functions, as well as third party legal, accounting, and other administrative costs. General and administrative expenses increased $0.5 million, or 10%, to $5.7 million in the three months ended March 31, 2021 compared to $5.2 million in the three months ended March 31, 2020. As a percentage of revenue, general and administrative expenses decreased to 20% in the three months ended March 31, 2021 from 22% in the three months ended March 31, 2020. The increase in general and administrative expenses is primarily due to higher personnel-related costs resulting from our increased headcount during the three months ended March 31, 2021 compared to the same period in 2020.

#### Acquisition-Related Costs and Expenses

Acquisition-related costs and expenses include amortization of intangible assets, expenses recorded due to changes in the fair value of contingent consideration, stock-based compensation, and other costs associated with acquisitions. Acquisition-related costs and expenses increased $0.1 million, or 5%, to $1.7 million in the three months ended March 31, 2021 compared to $1.6 million in the three months ended March 31, 2020. As a percentage of revenue, acquisition-related costs and expenses decreased to 6% in the three months ended March 31, 2021 from 7% in the three months ended March 31, 2020. The increase in acquisition-related costs and expenses is due to the impact of foreign exchange rates on the amortization of certain intangible assets during the three months ended March 31, 2021 compared to the same period in 2020.

#### Restructuring Costs

Restructuring costs consist of employee severance obligations and other related costs. There were no restructuring costs in the three months ended March 31, 2021. Restructuring costs were negative $0.1 million in the three months ended March 31, 2020 and are due to a reversal of costs accrued for the restructuring plan implemented in June 2019.

#### Interest Expense

Interest expense includes the amortization of debt discount and issuance costs and coupon interest incurred associated with our 0.75% convertible senior notes due 2026 (the “2026 Notes”). Interest expense was $1.3 million for the three months ended March 31, 2021 and consisted of $1.1 million of amortization of debt discount and issuance costs and $0.2 million of coupon interest incurred. There was no interest expense in the three months ended March 31, 2020.

#### Other Income, Net

Other income, net includes interest income net of amortization and net realized gains or losses on our marketable securities portfolio, foreign currency transactional gains or losses, and the change in fair value of our convertible senior notes hedge and embedded conversion derivative. Other income, net increased $0.3 million, to $0.4 million in the three months ended March 31, 2021 compared to $32,000 in the three months ended March 31, 2020. This increase is primarily due to an increase in interest income as a result of higher cash and investment balances and an overall foreign currency exchange transactional gain recorded during the three months ended March 31, 2021 as compared to an overall foreign currency exchange transactional loss recorded during the same period in 2020.

#### Income Tax Benefit (Provision)

For the three months ended March 31, 2021, we recorded an income tax provision of $0.4 million, which yielded an effective tax rate of 29%. For the three months ended March 31, 2020, we recorded an income tax provision of $0.2 million, or an effective tax rate of 17%. The difference between the U.S. federal statutory tax rate and our effective tax rate for the three months ended March 31, 2021 and 2020 was primarily due to the impact of foreign and state taxes, the impact of certain permanent items on its tax provision, and the impact of federal and state research and development credits on its tax provision.

### Comparison of the Six Months Ended March 31, 2021 and 2020

The following table summarizes certain aspects of our results of operations for the six months ended March 31, 2021 and 2020 (*amounts in thousands, except percentages):*

| Revenue | Six Months Ended March 31, 2021 | 2020 | Percentage of Total Revenue 2021 | 2020 | Increase (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Software and hardware | $25,315 | $22,968 | 46% | 51% | $2,347 | 10% |
| Services and other | 29,433 | 22,291 | 54% | 49% | 7,142 | 32% |
| Total revenue | $54,748 | $45,259 | 100% | 100% | $9,489 | 21% |
| Cost of revenue | 7,930 | 6,119 | 14% | 14% | 1,811 | 30% |
| Selling and marketing | 15,915 | 13,334 | 29% | 29% | 2,581 | 19% |
| Research and development | 12,855 | 10,873 | 23% | 24% | 1,982 | 18% |
| General and administrative | 10,776 | 10,498 | 20% | 23% | 278 | 3% |
| Acquisition-related costs and expenses | 3,352 | 3,187 | 6% | 7% | 165 | 5% |
| Restructuring costs | — | (114) | —% | —% | 114 | (100)% |
| Interest expense | 1,319 | — | 2% | —% | 1,319 | 100% |
| Other income, net | 468 | 335 | 1% | 1% | 133 | 40% |
| Income tax benefit (provision) | 117 | (229) | —% | (1)% | 346 | (151)% |
| Net income | $3,186 | $1,468 | 6% | 3% | $1,718 | 117% |

31

#### Revenue

Total revenue increased $9.5 million or 21%, to $54.7 million in the six months ended March 31, 2021 compared to $45.3 million in the six months ended March 31, 2020. Software and hardware revenue increased $2.3 million, or 10%, to $25.3 million in the six months ended March 31, 2021 compared to $23.0 million in the six months ended March 31, 2020 primarily due to an increase in sales of our Mobile Deposit®, ID\_CLOUD™, and CheckReader™ software products and identity verification hardware products. Services and other revenue increased $7.1 million, or 32%, to $29.4 million in the six months ended March 31, 2021 compared to $22.3 million in the six months ended March 31, 2020 primarily due to strong growth in Mobile Verify® transactional SaaS revenue of $5.3 million in the six months ended March 31, 2021 compared to the same period in 2020, as well as an increase in maintenance revenue associated with CheckReader™ and Mobile Deposit® software sales and hosted mobile deposit transactional revenue.

#### Cost of Revenue

Cost of revenue includes personnel costs related to billable services and software support, direct costs associated with our hardware products, hosting costs, and the costs of royalties for third party products embedded in our products. Cost of revenue increased $1.8 million, or 30%, to $7.9 million in the six months ended March 31, 2021 compared to $6.1 million in the six months ended March 31, 2020. As a percentage of revenue, cost of revenue was consistent at 14% in each of the six months ended March 31, 2021 and 2020. The increase in cost of revenue is primarily due to an increase in variable personnel, hosting and royalty costs associated with a higher volume of Mobile Verify® transactions processed during the six months ended March 31, 2021 compared to the same period in 2020.

#### Selling and Marketing Expenses

Selling and marketing expenses include payroll, employee benefits, stock-based compensation, and other headcount-related costs associated with sales, marketing, and product management personnel. Selling and marketing expenses also include non-billable costs of professional services personnel, advertising expenses, product promotion costs, trade shows, and other brand awareness programs. Selling and marketing expenses increased $2.6 million, or 19%, to $15.9 million in the six months ended March 31, 2021 compared to $13.3 million in the six months ended March 31, 2020. As a percentage of revenue, selling and marketing expenses were consistent at 29% in each of the six months ended March 31, 2021 and 2020. The increase in selling and marketing expense is primarily due to higher personnel-related costs resulting from our increased headcount of $3.0 million and higher product promotion costs of $0.4 million in the six months ended March 31, 2021 compared to the same period in 2020. The overall increase in selling and marketing expense was partially offset by a decrease in travel and related expenses of $0.8 million as a result of the COVID-19 pandemic.

#### Research and Development Expenses

Research and development expenses include payroll, employee benefits, stock-based compensation, third party contractor expenses, and other headcount-related costs associated with software engineering and mobile capture science. Research and development expenses increased $2.0 million, or 18%, to $12.9 million in the six months ended March 31, 2021 compared to $10.9 million in the six months ended March 31, 2020. As a percentage of revenue, research and development expenses decreased to 23% in the six months ended March 31, 2021 from 24% in the six months ended March 31, 2020. The increase in research and development expenses is primarily due to higher personnel-related costs resulting from our increased headcount in the six months ended March 31, 2021 compared to the same period in 2020.

#### General and Administrative Expenses

General and administrative expenses include payroll, employee benefits, stock-based compensation, and other headcount-related costs associated with finance, legal, administration, and information technology functions, as well as third party legal, accounting, and other administrative costs. General and administrative expenses increased $0.3 million, or 3%, to $10.8 million in the six months ended March 31, 2021 compared to $10.5 million in the six months ended March 31, 2020. As a percentage of revenue, general and administrative expenses decreased to 20% in the six months ended March 31, 2021 from 23% in the six months ended March 31, 2020. The increase in general and administrative expenses is primarily due to higher personnel-related costs resulting from our increased headcount of $0.7 million during the six months ended March 31, 2021 compared to the same period in 2020. This increase is partially offset by a decrease in intellectual property litigation costs of $0.5 million.

#### Acquisition-Related Costs and Expenses

Acquisition-related costs and expenses include amortization of intangible assets, expenses recorded due to changes in the fair value of contingent consideration, stock-based compensation, and other costs associated with acquisitions. Acquisition-related costs and expenses increased $0.2 million, or 5%, to $3.4 million in the six months ended March 31, 2021 compared to $3.2 million in the six months ended March 31, 2020. As a percentage of revenue, acquisition-related costs and expenses decreased to 6% in the six months ended March 31, 2021 from 7% in the six months ended March 31, 2020. The increase in acquisition-related costs and expenses is primarily due to the impact of foreign exchange rates on the amortization of certain intangible assets during the six months ended March 31, 2021 compared to the same period in 2020.

#### Restructuring Costs

Restructuring costs consist of employee severance obligations and other related costs. There were no restructuring costs in the six months ended March 31, 2021. Restructuring costs were negative $0.1 million in the six months ended March 31, 2020 due to a reversal of costs accrued for the restructuring plan implemented in June 2019.

#### Interest Expense

Interest expense includes the amortization of debt discount and issuance costs and coupon interest incurred associated with our 2026 Notes. Interest expense was $1.3 million for six months ended March 31, 2021 and consisted of $1.1 million of amortization of debt discount and issuance costs and $0.2 million of coupon interest incurred. There was no interest expense in the six months ended March 31, 2020.

#### Other Income, Net

Other income, net includes interest income net of amortization and net realized gains or losses on our marketable securities portfolio, foreign currency transactional gains or losses, and the change in fair value of our convertible senior notes hedge and embedded conversion derivative. Other income, net increased $0.2 million, to $0.5 million of net income in the six months ended March 31, 2021 compared to $0.3 million of net income in the six months ended March 31, 2020, primarily due to an increase in interest income as a result of higher cash and investment balances and a higher foreign currency exchange transactional gain.

#### Income Tax Benefit (Provision)

For the six months ended March 31, 2021, we recorded an income tax benefit of $0.1 million, which yielded an effective tax rate of negative 4%. For the six months ended March 31, 2020, we recorded an income tax provision of $0.2 million, or an effective tax rate of 13%. The difference between the U.S. federal statutory tax rate and our effective tax rate for the six months ended March 31, 2021 and 2020 was primarily due to excess tax benefits resulting from the exercise of stock options and vesting of restricted stock, the impact of foreign and state taxes, the impact of certain permanent items on its tax provision, and the impact of federal and state research and development credits on its tax provision.

### Liquidity and Capital Resources

On March 31, 2021, we had $219.5 million in cash and cash equivalents and investments compared to $62.0 million on September 30, 2020, an increase of $157.5 million, or 254%. The increase in cash and cash equivalents and investments is primarily due to net proceeds from the issuance of the 2026 Notes of $140.4 million (net of sale of warrants and purchase of convertible senior notes hedge), net cash provided by operating activities of $16.1 million, and proceeds from the issuance of our common stock, par value $0.001 (“Common Stock”) under our equity plan of $2.8 million. These increases were partially offset by the payment of acquisition-related contingent consideration of $0.8 million and capital expenditures of $0.7 million.

#### Cash Flows from Operating Activities

Net cash provided by operating activities during the six months ended March 31, 2021 was $16.1 million and resulted primarily from net income of $3.2 million, net non-cash charges of $10.8 million, and favorable changes in operating assets and liabilities of $2.0 million. The primary non-cash adjustments to operating activities were stock-based compensation expense, amortization of intangible assets, accretion and amortization on debt securities & other, depreciation and amortization, and amortization of investment premiums and other totaling $5.7 million, $3.4 million, $1.1 million, $0.8 million, and $0.3 million, respectively, which were partially offset by a deferred tax benefit of $0.5 million.

Net cash provided by operating activities during the six months ended March 31, 2020 was $8.4 million and resulted primarily from net income of $1.5 million adjusted for non-cash charges of $9.0 million as well as favorable changes in operating assets and liabilities of $2.1 million. The primary non-cash adjustments to operating activities were stock-based compensation expense, amortization of intangible assets, depreciation and amortization, and deferred taxes totaling $4.6 million, $3.2 million, and $0.7 million and $0.5 million, respectively.

#### Cash Flows from Investing Activities

Net cash used in investing activities was $124.7 million during the six months ended March 31, 2021, which consisted primarily of net purchases of investments of $124.1 million and capital expenditures of $0.7 million.

Net cash used in investing activities was $7.8 million during the six months ended March 31, 2020, which consisted primarily of net purchases of investments of $7.4 million and capital expenditures of $0.4 million.

#### Cash Flows from Financing Activities

Net cash provided by financing activities was $142.6 million during the six months ended March 31, 2021, which consisted of net proceeds from the issuance of the 2026 Notes of $149.7 million, proceeds from the issuance of equity plan Common Stock of $2.8 million, and proceeds from other borrowings of $0.3 million partially offset by net cash used for the call spreads on the sales and purchases of warrants and convertible senior notes hedge issued in connection with the 2026 Notes of $9.3 million, and payment of acquisition-related contingent consideration of $0.8 million.

Net cash used in financing activities was $0.3 million during the six months ended March 31, 2020, which consisted of repurchases and retirements of Common Stock of $1.0 million, payment of acquisition-related contingent consideration of $0.5 million, and principal payments on other borrowings of $0.1 million, partially offset by net proceeds from the issuance of equity plan Common Stock of $1.3 million.

#### 0.75% Convertible Senior Notes due 2026

In February 2021, the Company issued $155.3 million aggregate principal amount of the 2026 Notes. The 2026 Notes are senior unsecured obligations of the Company. The 2026 Notes were issued pursuant to an Indenture, dated February 5, 2021 (the “Indenture”), between the Company and UMB Bank, National Association, as trustee. The Indenture includes customary covenants and sets forth certain events of default after which the 2026 Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the 2026 Notes become automatically due and payable.

The net proceeds from this offering were approximately $149.7 million, after deducting the Initial Purchasers’ discounts and commissions and the Company’s estimated offering expenses related to the offering. The 2026 Notes will mature on February 1, 2026, unless earlier redeemed, repurchased or converted. The 2026 Notes will bear interest from February 5, 2021 at a rate of 0.750% per year payable semiannually in arrears on February 1 and August 1 of each year, beginning on August 1, 2021. The 2026 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding August 1, 2025, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2021, if the last reported sale price per share of the Company’s common stock, $0.001 par value (the “Common Stock”) exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Common Stock on such trading day and the conversion rate on such trading day; and (3) upon the occurrence of certain corporate events or distributions on the Common Stock. On or after August 1, 2025, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of the 2026 Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. Upon conversion, the Company may satisfy its conversion obligation by paying and/or delivering, as the case may be, cash and, if applicable at the Company’s election, shares of the Common Stock, based on the applicable conversion rate(s); provided that the Company will be required to settle conversions solely in cash unless and until the Company (i) receives stockholder approval to increase the number of authorized shares of the Common Stock and (ii) reserves such amount of shares of the Common Stock for future issuance as required pursuant to the indenture that will govern the 2026 Notes. The conversion rate for the 2026 Notes will initially be 47.9731 shares of the Common Stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $20.85 per share of the Common Stock. The initial conversion price of the 2026 Notes represents a premium of approximately 37.5% to the $15.16 per share last reported sale price of the Common Stock on February 2, 2021. The conversion rate is subject to adjustment under certain circumstances in accordance with the terms of the Indenture. The impact of the convertible feature will be dilutive to our earnings per share when our average stock price for the period is greater than the conversion price.

In connection with the issuance of the 2026 Notes, we entered into transactions for convertible notes hedge (the “Notes Hedge”) and warrants (the “Warrant Transactions”). The Notes Hedge was entered into with Bank of America, N.A., Jefferies International Limited and Goldman Sachs & Co. LLC, and provided the Company with the option to acquire, on a net settlement basis, approximately 7.4 million shares of common stock at a strike price of $20.85, which is equal to the number of shares of common stock that notionally underlie and corresponds to the conversion price of the 2026 Notes. The cost of the Notes Hedge was $33.2 million. The Notes Hedge will expire on February 1, 2026, equal to the maturity date of the 2026 Notes. The Notes Hedge is expected to reduce the potential equity dilution upon conversion of the 2026 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the Notes Hedge.

In addition, the Warrant Transactions provided us with the ability to acquire up to 7.4 million shares of our common stock. The Warrant Transactions will expire ratably during the 80 trading days commencing on and including May 1, 2026 and may be settled in net shares of common stock or net cash at the Company’s election. We received $23.9 million in cash proceeds from the Warrant Transactions. As a result of the Warrant Transactions, the Company is required to recognize incremental dilution of earnings per share to the extent the average share price is over $26.53 for any fiscal quarter.

#### Rights Agreement

On October 23, 2018, we entered into the Section 382 Rights Agreement (the “Rights Agreement”) and issued a dividend of one preferred share purchase right (a “Right”) for each share of Common Stock payable on November 2, 2018 to the stockholders of record of such shares on that date. Each Right entitles the registered holder, under certain circumstances, to purchase from us one one-thousandth of a share of Series B Junior Preferred Stock, par value $0.001 per share (the “Preferred Shares”), of the Company, at a price of $35.00 per one one-thousandth of a Preferred Share represented by a Right, subject to adjustment. The description and terms of the Rights are set forth in the Rights Agreement.

The Rights are not exercisable until the Distribution Date (as defined in the Rights Agreement). Until a Right is exercised, the holder thereof, as such, will have no rights as a stockholder of the Company, including, without limitation, the right to vote or to receive dividends.

At any time prior to the time any Person becomes an Acquiring Person (as defined in the Rights Agreement), the Board may redeem the Rights in whole, but not in part, at a price of $0.0001 per Right (the “Redemption Price”). The redemption of the Rights may be made effective at such time, on such basis and with such conditions as the Board in its sole discretion may establish. Immediately upon any redemption of the Rights, the right to exercise the Rights will terminate and the only right of the holders of Rights will be to receive the Redemption Price.

The Rights will expire on the earlier of (i) the close of business on October 22, 2021, (ii) the time at which the Rights are redeemed, and (iii) the time at which the Rights are exchanged.

#### Share Repurchase Program

On December 13, 2019, the Board authorized and approved a share repurchase program for up to $10 million of the currently outstanding shares of our Common Stock. The share repurchase program expired on December 16, 2020. Total purchases made under the share repurchase program were $1.0 million or approximately 137,000 shares at an average price of $7.33. The purchases under the share repurchase program were made through open market trades.

#### CARES Act

On March 27, 2020, President Trump signed into law the “Coronavirus Aid, Relief and Economic Security (CARES) Act.” The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. We continue to examine the impacts the CARES Act may have on our business.

#### Other Liquidity Matters

On March 31, 2021, we had investments of $165.6 million, designated as available-for-sale debt securities, which consisted of commercial paper, corporate issuances, and asset-backed securities, carried at fair value as determined by quoted market prices for identical or similar assets, with unrealized gains and losses, net of tax, and reported as a separate component of stockholders’ equity. All securities whose maturity or sale is expected within one year are classified as “current” on the consolidated balance sheets. All other securities are classified as “long-term” on the consolidated balance sheets. At March 31, 2021, we had $131.3 million of our available-for-sale securities classified as current and $34.3 million of our available-for-sale securities classified as long-term. At September 30, 2020, we had $40.0 million of our available-for-sale securities classified as current and $2.0 million of our available-for-sale securities classified as long-term.

We had working capital of $182.6 million at March 31, 2021 compared to $59.8 million at September 30, 2020.

Based on our current operating plan, we believe the current cash and cash equivalents and cash expected to be generated from operations will be adequate to satisfy our working capital needs for the next twelve months from the date the financial statements are filed.

### Off Balance Sheet Arrangements

The Company had no off balance sheet arrangements as of March 31, 2021.

### Changes in Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S. The preparation of the consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosure of contingent assets and liabilities. We review our estimates on an on-going basis, including those related to revenue recognition, stock-based compensation, income taxes and the valuation of goodwill, intangibles and other long-lived assets. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. The critical accounting policies and estimates used in the preparation of our consolidated financial statements are described in Item 7—“Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the Form 10-K for the year ended September 30, 2020.

In February 2021, the Company issued the 2026 Notes. Concurrently with the issuance of the 2026 Notes, the Company entered into the Notes Hedge and Warrant Transactions. See *Convertible Senior Notes Hedge and Embedded Conversion Derivative* in Note 1.

“Nature of Operations and Summary of Significant Accounting Policies” for our new policy surrounding these items and Note 7. “Convertible Senior Notes” for additional information related to these transactions. Other than the aforementioned, there have been no other material changes to our critical accounting policies and estimates from those disclosed in our Annual Report on Form 10-K for the year ended September 30, 2020.

## Market risk

As filed, 2,632 characters.

#### Interest Rates

The primary objective of our investment activities is to preserve principal while at the same time maximizing after-tax yields without significantly increasing risk. To achieve this objective, we maintain our investment portfolio of cash equivalents and marketable securities in a variety of securities, including corporate debt securities, commercial paper, certificates of deposit, and asset-backed securities. We have not used derivative financial instruments in our investment portfolio, and none of our investments are held for trading or speculative purposes. Short-term and long-term debt securities are generally classified as available-for-sale and consequently are recorded on the consolidated balance sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income, net of estimated tax. As of March 31, 2021, our marketable securities had remaining maturities between approximately one and 42 months and a fair market value of $165.6 million, representing 47% of our total assets.

The fair value of our cash equivalents and debt securities is subject to change as a result of changes in market interest rates and investment risk related to the issuers’ credit worthiness. We do not utilize financial contracts to manage our investment portfolio’s exposure to changes in market interest rates. A hypothetical 100 basis point increase or decrease in market interest rates would not have a material impact on the fair value of our cash equivalents and debt securities due to the relatively short maturities of these investments. While changes in market interest rates may affect the fair value of our investment portfolio, any gains or losses will not be recognized in our results of operations until the investment is sold or if the reduction in fair value was determined to be an other-than-temporary impairment.

#### Foreign Currency Risk

As a result of past acquisitions, we have operations in France, the Netherlands, and Spain that are exposed to fluctuations in the foreign currency exchange rate between the U.S. dollar, the Euro, and the British pound sterling. The functional currency of our French, Dutch, and Spanish operations is the Euro. Our results of operations and cash flows are subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the Euro. Translation adjustments resulting from translating the functional currency financial statements into U.S. dollar equivalents are reported separately in the consolidated statements of operations and other comprehensive income (loss).

## Controls and procedures

As filed, 2,376 characters.

### Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures as of the end of the period covered by this Form 10-Q pursuant to Exchange Act Rules 13a-15(b) and 15d-15(b). In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in *Internal Control – Integrated Framework (2013)*. We recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2021.

### Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended March 31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

### PART II

### OTHER INFORMATION

## Risk factors

As filed, 16,312 characters.

While we attempt to identify, manage, and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. Item 1A—“Risk Factors” in the Form 10-K describes some of the risks and uncertainties associated with our business, which we strongly encourage you to review. These risks and uncertainties have the potential to materially affect our business, financial condition, results of operations, cash flows, projected results, and future prospects. There have been no material changes in our risk factors from those disclosed in the Form 10-K, except as noted below.

### Risks Associated With Our Indebtedness

***Our indebtedness and liabilities could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations and impair our ability to satisfy our obligations under the 2026 Notes.***

In February 2021, we issued $155.3 million aggregate principal amount of the 2026 Notes and may also incur additional indebtedness to meet future financing needs. Our indebtedness could have significant negative consequences for our security holders and our business, results of operations and financial condition by, among other things:

- making it difficult for us to satisfy our obligations, including debt service obligations;
- increasing our vulnerability to adverse economic and industry conditions;
- limiting our ability to obtain additional financing or refinance debt;
- requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, which will reduce the amount of cash available for other purposes;
- limiting our flexibility to plan for, or react to, changes in our business and the industry in which we operate;
- diluting the interests of our existing stockholders as a result of issuing shares of our common stock upon conversion of the 2026 Notes; and
- placing us at a possible competitive disadvantage with competitors that are less leveraged than us or have better access to capital.

Our business may not generate sufficient funds, and we may otherwise be unable to maintain sufficient cash reserves, to pay amounts due under our indebtedness, and our cash needs may increase in the future. In addition, any future indebtedness that we may incur may contain financial and other restrictive covenants that limit our ability to operate our business, raise capital or make payments under our other indebtedness. If we fail to comply with these covenants or to make payments under our indebtedness when due, then we would be in default under that indebtedness, which could, in turn, result in that and our other indebtedness becoming immediately payable in full.

***We may be unable to raise the funds necessary to repurchase the 2026 Notes for cash following a fundamental change, or to pay any cash amounts due upon conversion, and our future indebtedness may limit our ability to repurchase the 2026 Notes or pay cash upon their conversion.***

Holders of the 2026 Notes may in certain circumstances require us to repurchase their 2026 Notes following a fundamental change at a cash repurchase price generally equal to the principal amount of the 2026 Notes to be repurchased, plus accrued and unpaid interest, if any. In addition, upon conversion, we will satisfy all of our conversion obligation in cash until we receive stockholder approval and thereafter, part or all of such conversion obligation in cash. We may not have enough available cash or be able to obtain financing at the time we are required to repurchase the 2026 Notes or pay the cash amounts due upon conversion. In addition, applicable law, regulatory authorities and the agreements governing our other indebtedness may restrict our ability to repurchase the 2026 Notes or pay the cash amounts due upon conversion. Our failure to repurchase 2026 Notes or to pay the cash amounts due upon conversion when required will constitute a default under the Indenture. A default under the Indenture or the fundamental change itself could also lead to a default under agreements governing our other indebtedness, which may result in that other indebtedness becoming immediately payable in full. We may not have sufficient funds to satisfy all amounts due under the other indebtedness and the 2026 Notes.

***Provisions in the 2026 Notes Indenture could delay or prevent an otherwise beneficial takeover of us.***

Certain provisions in the 2026 Notes and the Indenture could make a third party attempt to acquire us more difficult or expensive. For example, if a takeover constitutes a fundamental change, then holders of the 2026 Notes will have the right to require us to repurchase their 2026 Notes for cash. In addition, if a takeover constitutes a make-whole fundamental change, then we may be required to temporarily increase the conversion rate. In either case, and in other cases, our obligations under the 2026 Notes and the Indenture could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management, including in a transaction that holders of our common stock may view as favorable.

***The accounting method for the 2026 Notes could adversely affect our reported financial condition and results.***

***The accounting method for reflecting the 2026 Notes on our balance sheet, accruing interest expense for the 2026 Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our reported earnings and financial condition.***

As described in Note 7. “Convertible Senior Notes” to the consolidated financial statements included in this Form 10-Q, we will be required to settle conversions of the 2026 Notes entirely in cash unless and until we (1) receive stockholder approval to increase the number of authorized shares of our common stock and (2) reserve such amount of shares of common stock for future issuance as required pursuant to the Indenture that governs the 2026 Notes. Accordingly, the conversion option that is part of the 2026 Notes will be accounted for as a derivative pursuant to accounting standards relating to derivative instruments and hedging activities. In general, this will result in an initial valuation of the conversion option, which will be bifurcated from the debt component of the 2026 Notes, resulting in an original issue discount. The original issue discount will be accreted to interest expense over the term of the 2026 Notes, which will result in an effective interest rate reported in our consolidated statements of operations and comprehensive income significantly in excess of the stated coupon rate of the 2026 Notes.

This accounting treatment will reduce our earnings and could adversely affect the price at which our common stock trades, but it will not affect the amount of cash interest paid to holders of the 2026 Notes or our cash flows.

For each financial statement period after issuance of the 2026 Notes unless and until we obtain the stockholder approval described in Note 7. “Convertible Senior Notes” to the consolidated financial statements included in this Form 10-Q, a gain (or loss) will be reported in our consolidated statements of operations and other comprehensive income to the extent the valuation of the conversion option changes from the previous period. The Notes Hedge transactions will also be accounted for as a derivative instrument until such time that we receive stockholder approval to increase our authorized share count by a sufficient number of shares as required under the Indenture, offsetting the gain (or loss) associated with changes to the valuation of the conversion option. Although we do not expect there to be a material net impact to our consolidated statements of operations and comprehensive income as a result of our issuing the 2026 Notes and entering into the Notes Hedge, we cannot assure you that these transactions will be completely offset, which may result in volatility to our consolidated statements of operations and comprehensive income.

If we obtain stockholder approval, we expect that, under applicable accounting principles, we will continue carrying on the balance sheet a debt discount for accounting purposes, which will be accreted into interest expense over the term of the 2026 Notes. As a result of this accretion, the interest expense that we expect to recognize for the 2026 Notes for accounting purposes will be greater than the cash interest payments we will pay on the 2026 Notes, which will result in lower reported income or higher reported loss. The lower reported income or higher reported loss resulting from this accounting treatment could depress the trading price of our common stock. However, in August 2020, the Financial Accounting Standards Board published an Accounting Standards Update, which we refer to as ASU 2020-06 and which will be required to be effective for us for fiscal years beginning after December 15, 2021 (or, in the case of smaller reporting companies, December 15, 2023), including interim periods within those fiscal years. However, early adoption is permitted in certain circumstances for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. When effective, we expect that ASU 2020-06 will eliminate the separate accounting described above and reduce the interest expense that we expect to recognize for the 2026 Notes for accounting purposes. We expect that we will early adopt ASU 2020-06 beginning in our fiscal year 2022, commencing as of October 1, 2021.

In addition, we expect to be eligible to use the treasury stock method to reflect the shares underlying the 2026 Notes in our diluted earnings per share. Under this method, if the conversion value of the 2026 Notes exceeds their principal amount for a reporting period, then we will calculate our diluted earnings per share assuming that all the 2026 Notes were converted and that we issued shares of our common stock to settle the excess. However, if reflecting the 2026 Notes in diluted earnings per share in this manner is anti-dilutive, or if the conversion value of the 2026 Notes does not exceed their principal amount for a reporting period, then the shares underlying the 2026 Notes will not be reflected in our diluted earnings per share. In addition, if accounting standards change in the future and we are not permitted to use the treasury stock method, then our diluted earnings per share may decline. For example, ASU 2020-06 amends these accounting standards, effective as of the dates referred to above, to eliminate the treasury stock method for convertible instruments and instead require application of the “if converted” method. Under the “if-converted” method, diluted earnings per share would generally be calculated assuming that all the 2026 Notes were converted at the beginning of the reporting period, unless the result would be anti-dilutive. The application of the if-converted method may reduce our reported diluted earnings per share. Because we are required, upon conversion of any 2026 Notes, to settle the conversion value in cash up to at least the principal amount of 2026 Notes being converted, we currently expect that the application of the “if-converted” method to the 2026 Notes under ASU 2020-06 will be substantially similar to the treasury stock method described above.

Furthermore, if any of the conditions to the convertibility of the 2026 Notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of the 2026 Notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders convert their 2026 Notes and could materially reduce our reported working capital.

***The conditional conversion feature of the 2026 Notes, if triggered, may adversely affect our financial condition and operating results.***

In the event the conditional conversion feature of the 2026 Notes is triggered, holders of 2026 Notes will be entitled to convert the 2026 Notes at any time during specified periods at their option. If one or more holders elect to convert their 2026 Notes, we would be required to settle the conversion value solely in cash until we receive stockholder approval and thereafter, up to at least the principal amount being converted which could adversely affect our liquidity.

### Risks Related to Investing in Our Common Stock

***The Notes Hedge and Warrant Transactions may affect the value of our common stock.***

In connection with the pricing of the 2026 Notes, we entered into the Notes Hedge with the Option Counterparties. We also entered into Warrant Transactions with the Option Counterparties. The Notes Hedge is expected generally to reduce or offset potential dilution to our common stock upon any conversion of the 2026 Notes and/or offset any cash payments we may be required to make in excess of the principal amount of converted 2026 Notes, as the case may be. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of our common stock exceeds the strike price of the warrants.

The Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions from time to time prior to the maturity of the 2026 Notes (and are likely to do so during any observation period relating to a conversion of 2026 Notes). This activity could also cause or avoid an increase or a decrease in the market price of our common stock

The Option Counterparties may choose to engage in, or to discontinue engaging in, any of these transactions with or without notice at any time, and their decisions will be in their sole discretion.

***We will be subject to counterparty risk with respect to the Notes Hedge transactions.***

The Option Counterparties are financial institutions, and we will be subject to the risk that one or more of the Option Counterparties might default under their respective Notes Hedges. Our exposure to the credit risk of the Option Counterparties will not be secured by any collateral. Recent global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If any Option Counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under our transactions with such Option Counterparty.

Our exposure will depend on many factors, but, generally, the increase in our exposure will be correlated to the increase in the market price and in the volatility of our common stock. In addition, upon a default by any Option Counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of any of the Option Counterparties.

***Conversion of the 2026 Notes or exercise of the warrants evidenced by the Warrant Transactions may dilute the ownership interest of existing stockholders.***

Any stock issued upon conversion of the 2026 Notes will dilute the ownership interests of existing stockholders. Furthermore, the warrants evidenced by the Warrant Transactions are expected to be settled on a net-share basis. As a result, the conversion of some or all of the 2026 Notes or the exercise of some or all of such warrants may dilute the ownership interests of existing stockholders. Any sales in the public market of the shares of our common stock issuable upon such conversion of the 2026 Notes or such exercise of the warrants could adversely affect prevailing market prices of our common stock and, in turn, the price of the 2026 Notes. In addition, the existence of the 2026 Notes may encourage short selling by market participants because the conversion of the 2026 Notes could depress the price of our common stock.

Filed May 6, 2021.
Source: SEC EDGAR, the filing index for accession 0000807863-21-000063. Last ingested by Listed: Nov 11, 2026, 02:24 ET. No prices; not investment advice.
